Evidence map›Paper›PMID 40913839›Full record

ArticleSeminars in arthritis and rheumatism2025

MRI versus radiography as eligibility screening tool for knee osteoarthritis clinical trials: Data from the osteoarthritis initiative.

Ali Guermazi, Frank W Roemer, Erin L Ashbeck, John Lynch, C Kent Kwoh, Mohamed Jarraya

Abstract readComparative Study
In one paragraph

Article in Seminars in arthritis and rheumatism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ali GuermaziDepartment of Radiology, Boston University School of Medicine, Boston, MA, United States.
Frank W RoemerDepartment of Radiology, Boston University School of Medicine, Boston, MA, United States; Friedrich Alexander University Erlangen-Nürnberg (FAU) & University Hospital Erlangen, Erlangen, Germany.
Erin L AshbeckUniversity of Arizona Arthritis Center, University of Arizona College of Medicine, Tucson, AZ, United States; Statistics Consulting Lab, The BIO5 Institute, University of Arizona, Tucson, United States.
John LynchUniversity of California San Francisco, San Francisco, CA, United States.
C Kent KwohUniversity of Arizona Arthritis Center, University of Arizona College of Medicine, Tucson, AZ, United States.
Mohamed JarrayaDepartment of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. Electronic address: mjarraya@mgh.harvard.edu.

Funding

Identifying determinants of rapid structural and/or clinical progression in knee osteoarthritis by quantitative assessment of structural features on radiographsR01AR080742 · NIAMS · UNIVERSITY OF ARIZONA · PI JEFFREY W DURYEA, C KENT KWOH · 2022 to 2026
$3.7M
Unraveling the discordance between structural damage and pain phenotypes in knee osteoarthritisK23AR084603 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI Mohamed Jarraya · 2024 to 2026
$525k
NIAMS NIH HHS K23 AR084603NIAMS NIH HHS R01 AR080742
6 · The paper itself

Abstract

objectiveTo estimate the prevalence of knee structural pathologies that may warrant exclusion from disease-modifying osteoarthritis drug (DMOAD) trials, based on MRI versus radiography, among participants who would otherwise be considered eligible for enrollment based on commonly used radiographic inclusionary criteria.

methodsWe selected participants from the baseline visit of the Osteoarthritis Initiative that met radiographic structural and clinical eligibility criteria for a DMOAD clinical trial: Radiographic OA (Kellgren-Lawrence grade 2 or 3 with medial minimum joint space width ≥ 1.5 mm); and WOMAC knee pain score between 8 and 18 (0-20 scale). A musculoskeletal radiologist read radiographs and a shortened 3-T MRI protocol for structural pathologies that have been suggested as exclusionary from DMOAD clinical trial participation, as proposed by the Rapid Osteoarthritis MRI Eligibility Score (ROAMES), including meniscal root tears, subchondral insufficiency fractures, osteonecrosis, tumors and bone marrow infiltration, and acute traumatic changes.

resultsAmong 380 eligible participants (219 KL2 knees, 161 KL3 knees), structural pathologies that warrant exclusion from clinical trials were found in 38 knees (10 %) based on MRI, versus three knees (0.8 %) on radiography. Based on MRI, the estimated probability of an exclusionary finding in a KL2 knee was 0.06 (95 %CI: 0.03, 0.09), and 0.16 (95 %CI: 0.10, 0.21) in a KL3 knee. The most common finding was complete meniscus posterior root tear (31 knees, 8.2 %).

conclusionStructural pathologies that are unlikely to respond to investigational DMOADs were found in ∼10 % of eligible participants based on MRI screening, largely driven by complete meniscal root tears, while these findings were not visible on radiographs.

Indexed as

Knee JointMagnetic Resonance ImagingOsteoarthritis, KneePatient SelectionAgedClinical Trials as TopicFemaleHumansMaleMiddle AgedRadiographyClinical trialEligibilityKneeMeniscal root tearMRIOsteoarthritisRadiography

Identifiers

PMID40913839
PMCPMC12478175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.